Siemens has completed the investigation: the cause of the hematocrit discrepancy could not be determined from the information provided by the customer.The customer provided csv files including results for analytes other than hct.The customer could only provide raw data for failed tests.Without raw data (t_files) for the alleged discrepant results, it is not possible to reach a conclusive cause.A review of the in-house performance for card lot 10-21060-20 did not identify any product deficiencies.There was no indication of discrepant results at the time of product release (finished goods testing) nor during lifetime stability testing or retain lot testing.In addition, there were no other complaints received on card lot 10-21060-20.Therefore, there is no evidence that the system or reagent cards are not performing as intended.Sample handling (such as collection vessel, mixing and method of collection) are known to affect test results if proper precautions are not considered.The customer indicated that several samples were obtained directly from the bypass machine.It should be noted that improper sample mixing, including sample collection from a source with a non-uniform concentration can contribute to variation in test results and cannot be ruled out as a contributing factor.
|